Entity Details

Primary name EPCAM_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP16422
EntryNameEPCAM_HUMAN
FullNameEpithelial cell adhesion molecule
TaxID9606
Evidenceevidence at protein level
Length314
SequenceStatuscomplete
DateCreated1990-08-01
DateModified2021-06-02

Ontological Relatives

GenesEPCAM

GO terms

Show/Hide Table
GOName
GO:0005886 plasma membrane
GO:0005923 bicellular tight junction
GO:0008284 positive regulation of cell population proliferation
GO:0016021 integral component of membrane
GO:0016323 basolateral plasma membrane
GO:0016324 apical plasma membrane
GO:0016328 lateral plasma membrane
GO:0023019 signal transduction involved in regulation of gene expression
GO:0044877 protein-containing complex binding
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0048863 stem cell differentiation
GO:0050900 leukocyte migration
GO:0070062 extracellular exosome
GO:0098641 cadherin binding involved in cell-cell adhesion
GO:2000048 negative regulation of cell-cell adhesion mediated by cadherin
GO:2000648 positive regulation of stem cell proliferation

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction
Lateral cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000716 Thyroglobulin type-1DomainDomain
IPR036857 Thyroglobulin type-1 superfamilyFamilyHomologous superfamily
IPR041630 Epithelial cell adhesion molecule N-terminal domainDomainDomain
IPR043406 Transmembrane glycoprotein EPCAM/Trop-2FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613217 OMIMDiarrhea 5, with tufting enteropathy, congenital (DIAR5)An intractable diarrhea of infancy characterized by villous atrophy and absence of inflammation, with intestinal epithelial cell dysplasia manifesting as focal epithelial tufts in the duodenum and jejunum. The disease is caused by variants affecting the gene represented in this entry.
613244 OMIMHereditary non-polyposis colorectal cancer 8 (HNPCC8)An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. The disease is caused by variants affecting the gene represented in this entry. HNPCC8 results from heterozygous deletion of 3-prime exons of EPCAM and intergenic regions directly upstream of MSH2, resulting in transcriptional read-through and epigenetic silencing of MSH2 in tissues expressing EPCAM.

Drugs

Show/Hide Table
DrugNameSourceType
DB05319 Oportuzumab monatoxDrugbankbiotech
DB05831 ING-1Drugbanksmall molecule
DB06607 CatumaxomabDrugbankbiotech
DB09336 Technetium Tc-99m nofetumomab merpentanDrugbanksmall molecule
DB11075 HypromelloseDrugbanksmall molecule